{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001962","form_type":"8-K/A","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2024-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.125300+00:00","generated_at":"2026-06-07T00:53:32.301039+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"INVO Bioscience amends merger terms, extends deadline to April 30, 2024; corrects NAYA share count to 1M","bullets":["Second Amendment extends merger end date to April 30, 2024; interim private offering minimum reduced to $2M from $5M.","NAYA purchases 1M shares of Series A Preferred at $5/share per schedule; $500K due Dec 29 not yet received as of Jan 3.","Convertible Notes ($410K) maturity extended to June 30, 2024; conversion/exercise prices lowered to $2.25 from $10/$12.","CEO Steve Shum and CFO Andrea Goren salaries reverted to $260K and $215K on Jan 1, 2024 after temporary cut to $105K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001962","json":"https://secwatch.observer/filing/0001493152-24-001962.json","markdown":"https://secwatch.observer/filing/0001493152-24-001962.md","text":"https://secwatch.observer/filing/0001493152-24-001962.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/0001493152-24-001962-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:53:32.301039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6bddf0e78ea4ff98c8bea01c1cbb3481f34cd337","claim":"INVO Fertility, Inc. amended Convertible Notes extension with Required Holders (effective 2023-12-27).","evidence_excerpt":"As of December 27, 2023, the Company secured written consent by the Required Holders for the Convertible Note maturity date to be extended to June 30, 2024.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/0001493152-24-001962-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Required Holders"},{"label":"Effective","value":"2023-12-27"}],"fact_type":"material_agreement"},{"claim_id":"df44e1e8e73fdad49d5fef38b529137994719881","claim":"INVO Fertility, Inc. amended Second Amendment with NAYA Biosciences, Inc. (effective 2023-12-27).","evidence_excerpt":"On December 27, 2023, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into second amendment (“ Second Amendment ”) to the previously announced agreement and plan of merger (the “ Merger Agreement ”) by and among the Company, INVO Merger Sub, Inc. (“ Merger Sub ”), and NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/0001493152-24-001962-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"NAYA Biosciences, Inc."},{"label":"Effective","value":"2023-12-27"}],"fact_type":"material_agreement"},{"claim_id":"e85b1d6e9e5407e31fbb5de41ef2e7260f3adc3d","claim":"INVO Fertility, Inc. entered into SPA with NAYA valued at $5.00 per share (effective 2023-12-29).","evidence_excerpt":"On December 29, 2023, the Company entered into a securities purchase agreement (the “ SPA ”) with NAYA for NAYA’s purchase of 1,000,000 shares of the Company’s Series A Preferred Stock at a purchase price of $5.00 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224001962/0001493152-24-001962-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"NAYA"},{"label":"Value","value":"$5.00 per share"},{"label":"Effective","value":"2023-12-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}